Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions
Vascular Diseases
Interventions
OTHER

Placebo

DRUG

BMS-582949

DRUG

Atorvastatin

DRUG

Statin

Trial Locations (17)

10029

Mount Sinai School Of Medicine Imaging Science Laboratories, New York

19104

Hospital Of The University Of Pennsylvania, Philadelphia

28677

The Lipid Center, Statesville

32216

Jacksonville Center For Clinical Research - Univ Campus, Jacksonville

32626

Southeast Clinical Research, Llc, Chiefland

33609

Florida Cardiovascular Institute, Tampa

40213

L-Marc Research Center, Louisville

42431

Commonwealth Biomedical Research, Llc, Madisonville

45212

Metabolic And Atherosclerosis Research Center, Cincinnati

45219

Sterling Research Group, Cincinnati

46260

Phillip D. Toth, Md, Indianapolis

48098

Troy Internal Medince Pc/Research, Troy

55435

Radiant Research, Inc., Edina

75231

Radiant Research, Inc., Dallas

77030

Baylor College Of Medicine, Houston

78503

Mcallen Heart Clinic, McAllen

02114

Mgh Cardiac Mr Pet Ct Program, Boston

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY